Can off-label cancer drugs help children? a national study aims to find out
NCT ID NCT07727694
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This study collects safety and effectiveness data on cancer medicines used off-label or through compassionate access in children, adolescents, and young adults up to age 25 with pediatric malignancies. Participants are not enrolled in other treatment trials and are discussed by expert tumor boards. The goal is to gather real-world evidence on how these innovative drugs work in younger patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- off-label or compassionate-use cancer medicines (targeted therapies, immunotherapies, chemotherapies) approved in adults after 2007
- What this could lead to
- If successful, this could provide real-world evidence to support safer and more effective use of innovative cancer drugs in children and young adults.
- What could go wrong
- This is an observational data collection study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by incomplete data or differences in how patients are treated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHC Montlégia
NOT_YET_RECRUITINGLiège, 4000, Belgium
-
Cliniques Universitaires Saint-Luc
NOT_YET_RECRUITINGBrussels, 1200, Belgium
-
Hôpital Universitaire des Enfants Reine Fabiola (HUDERF)
NOT_YET_RECRUITINGBrussels, 1020, Belgium
-
University Hospital Antwerp
NOT_YET_RECRUITINGAntwerp, 2650, Belgium
-
University Hospital Gent
NOT_YET_RECRUITINGGhent, 9000, Belgium
-
University Hospital Leuven
RECRUITINGLeuven, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Virtual companion 'Ida' may ease cancer distress in kids
- Engineered immune cells target deadly brain tumors in children
- Could tiny needles tame Chemo's Gut-Wrenching side effect in kids?
- Buzzy, coaching, or kaleidoscope: which best calms kids during cancer shots?